01 Sep 2020 Oxurion NV reports first patient dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
13 Aug 2020 Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease Member news
11 Aug 2020 Precigen ActoBio announces positive topline results from Phase 1b study of AG019 ActoBiotics Member news
24 Jul 2020 Gilead en Galapagos kondigen positieve Europese CHMP opinie aan voor Jyseleca® (Filgotinib) voor de behandeling van volwassenen met matige tot ernstige reumatoïde artritis Member news
07 Jul 2020 Excelya welcomes three European contract research organizations to become one stop provider throughout Europe Member news
02 Jul 2020 Aligos Therapeutics and KU Leuven announce collaboration for the development of a therapeutic candidate targeting Coronavirus Member news
26 Jun 2020 US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings Member news
17 Jun 2020 eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
